Curet Pharmaceuticals Pvt Ltd
About Curet Pharmaceuticals Pvt Ltd
Data last updated:
Curet Pharmaceuticals Pvt Ltd is a private limited company based in Chandigarh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH1994PTC015380. Its GSTIN is 07AACCC3391D1ZY (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.58 Lakh. It is led by directors Jatinder Kapoor (Whole-Time Director) and Dharmesh Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 154 – 155 1st Floor Sector 17 – C, Chandigarh, India – 160017.
As per the financials filed for FY 2025, the company reported a revenue of ₹14 Lakh. For the same year it recorded a net profit of ₹4,560 (net margin 0.3%) and EBITDA of ₹20,322 (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSCO 154 – 155 1st Floor Sector 17 – C, Chandigarh, India – 160017
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Curet Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Curet Pharmaceuticals Pvt Ltd
FY 2025 filings availableCuret Pharmaceuticals Pvt Ltd reported revenue of ₹14 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹20,322 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹4,560 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.5% | |
| Net Profit Margin | 0.3% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curet Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Curet Pharmaceuticals Pvt Ltd
Curet Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatinder Kapoor | Whole-Time Director | 26 Jun 2000 | 26 Years 3 Months | Current |
| Dharmesh Kapoor | Director | 23 Jul 2018 | 8 Years 2 Months | Current |
Peer Comparison
Curet Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kamsom Pharmaceuticals Private Limited | ₹14.03 Lakh (FY 2022) | •••• | •••• | -81.0% | •••• | Rohtak, Haryana, India |
| Trumount Pharmaceuticals Private Limited | ₹14.02 Lakh (FY 2025) | •••• | •••• | -94.0% | •••• | Baddi, Himachal Pradesh, India |
| Accore Pharmaceuticals Private Limited | ₹14.01 Lakh (FY 2022) | •••• | •••• | 201.0% | •••• | Hyderabad, Telangana, India |
| Curet Pharmaceuticals Pvt Ltd this company | ₹14 Lakh (FY 2025) | •••• | •••• | •••• | Chandigarh, India | |
| Gaurisi Pharmaceuticals Private Limited | ₹13.97 Lakh (FY 2022) | •••• | •••• | 1161.0% | •••• | Lucknow, Uttar Pradesh, India |
| Dbrmd Pharmaceuticals Private Limited | ₹13.95 Lakh (FY 2018) | •••• | •••• | •••• | Kolkata, West Bengal, India |
Peers are the companies nearest to Curet Pharmaceuticals by revenue, above and below it, in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Curet Pharmaceuticals Pvt Ltd is audited by RAJESH MEHRA & ASOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESH MEHRA & ASOCIATES | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Curet Pharmaceuticals Pvt Ltd does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Curet Pharmaceuticals.
: available in the company report
Recent Activity
Curet Pharmaceuticals Pvt Ltd has 10 board changes on record since 2000: 6 appointments and 4 cessations. The latest: Ranjana Kapoor ceased to be Whole-Time Director on 11 Aug 2018.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Curet Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCC3391D1ZY | Delhi | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Curet Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 November 1994 (32+ years old) and is registered under CIN U24232CH1994PTC015380.
Curet Pharmaceuticals has 2 current directors:
- Jatinder Kapoor - Whole-Time Director
- Dharmesh Kapoor - Director
The latest financial statements of Curet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Curet Pharmaceuticals is 07AACCC3391D1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Curet Pharmaceuticals is U24232CH1994PTC015380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curet Pharmaceuticals was incorporated on 30 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Curet Pharmaceuticals by revenue are Kamsom Pharmaceuticals Private Limited, Trumount Pharmaceuticals Private Limited, Accore Pharmaceuticals Private Limited, Gaurisi Pharmaceuticals Private Limited, Dbrmd Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ranjana Kapoor ceased to be Whole-Time Director on 11 Aug 2018. Roopa Kapoor ceased to be Whole-Time Director on 11 Aug 2018. Saroj Dilbagi ceased to be Whole-Time Director on 11 Aug 2018. Curet Pharmaceuticals has 10 board changes on record in total.
The registered office of Curet Pharmaceuticals is at SCO 154 – 155 1st Floor Sector 17 – C, Chandigarh, India – 160017.
Curet Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Curet Pharmaceuticals is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.